Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the deep vein thrombosis market?

There has been a consistent growth in the market size of deep vein thrombosis in the past few years. It is projected to escalate from $1.06 billion in 2024, reaching $1.1 billion in 2025, with a compound annual growth rate (CAGR) of 4.1%. Factors such as the surge in specialized vascular medicine, the impact of medical guidelines, a heightened focus on thwarting thrombosis, developments in clinical research, and an increase in diagnosis awareness have contributed to its growth during the historical period.

What will be the deep vein thrombosis market size in the future?

The market size of deep vein thrombosis is projected to witness a consistent expansion in the coming years. The valuation will reach “$1.32 billion by 2029, with a CAGR of 4.6%. Factors contributing to this expansion during the forecast period include the increasing elderly population, the prevalence of lifestyle-related illnesses, focus on preventive healthcare, innovative treatments, and patient-centred care. Some of the major trends for the forecast period are awareness of risk factors, advances in diagnostic methods, treatment discoveries, public health campaigns, and prevention of post-operative complications.

Get your deep vein thrombosis market report here!

https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

What main drivers are fueling expansion in the deep vein thrombosis market?

The growth of the deep vein thrombosis market is likely to be driven by the rising count of individuals requiring treatment for deep vein thrombosis (DVT). The treatment for DVT involves the use of drugs such as anticoagulants and others designed to inhibit the formation of new blood clots and prevent the enlargement of existing ones, thereby mitigating the disease condition. The climbing number of patients in need of DVT treatment signifies a higher incidence of deep vein thrombosis, necessitating products for its diagnosis, prevention, and treatment. For example, the Centers for Disease Control and Prevention (CDC), a renowned public health agency in the US, reported in February 2023 that every year, around 900,000 people could be afflicted with deep vein thrombosis in the United States, and between 60,000 and 100,000 Americans could lose their lives to DVT or PE (pulmonary embolism) annually. Consequently, the escalating count of individuals in need of deep vein thrombosis (DVT) treatment is fuelling the market.

What key areas define the segmentation of the global deep vein thrombosis market?

The deep vein thrombosis market covered in this report is segmented –

1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class

2) By Treatment: Surgery, Drugs, Other Treatments

3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users

Subsegments:

1) By Anticoagulants: Direct Oral Anticoagulants (DOACs), Vitamin K Antagonists, Low Molecular Weight Heparins, Unfractionated Heparin

2) By Inferior Vena Cava Filters: Retrievable IVC Filters, Permanent IVC Filters, Advanced IVC Filter Systems

3) By Other Drug Class: Thrombolytics, Antiplatelet Agents, Fibrinolytics, Combination Therapy

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10616&type=smp

Who are the dominant players expanding their reach in the deep vein thrombosis market?

Major companies operating in the deep vein thrombosis market include Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Laboratorios Farmacéuticos Rovi S.A., Cardinal Health Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Pfizer Inc.

How are evolving market trends shaping deep vein thrombosis Strategies?

The emergence of product innovations is a growing trend in the deep vein thrombosis market that can’t be overlooked. To stay competitive, the main players in this market are embracing new technologies for product development. An example of this would be Penumbra Inc., a United States-based developer of novel therapies. In January 2023, they launched an advanced mechanical thrombectomy system called Lightning Flash that is developed to address venous and pulmonary thrombus. Key features of the system include Penumbra’s groundbreaking lightning-intelligent aspiration technology and innovative dual clot detection algorithms. Its intent is to rapidly eliminate large blood clots in the body such as venous thrombus and pulmonary emboli (PE). The system offers physicians a larger, higher torque-able catheter that is designed for the efficient removal of significant clot burdens in the pulmonary arteries or deep venous system, all while maintaining an excellent safety record.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10616

Which regions are emerging as leaders in the deep vein thrombosis market?

North America was the largest region in the deep vein thrombosis market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Blood Collection Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report

Vein Illuminator Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vein-illuminator-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: